Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, David Balakirouchenane, Jennifer Arrondeau, Pascaline Boudou‐Rouquette, Marie-Claire Bretagne, Joe‐Elie Salem, Xavier Declèves, Michel Vidal, N. Kramkimel, Sarah Guégan, S. Aractingi, Olivier Huillard, Jérôme Alexandre, Marie Wislez, François Goldwasser, Benoı̂t Blanchet
Topics & Concepts
CminMedicineDosingRegimenNivolumabConfidence intervalInternal medicinePopulationCancerUrologyPharmacokineticsCmaxEnvironmental healthImmunotherapyCancer Immunotherapy and BiomarkersMathematical Biology Tumor GrowthCAR-T cell therapy research